AlphaStocks
3.7
Weak

Insulet Corp (PODD)

As of Sep 20, 2026, Insulet Corp (PODD) scores 3.7/10 on AlphaStocks' five-model composite, #145 of 168 Health Care stocks. At $141, PODD trades 32% above its model fair value of $107.

Health Care / Health Care Equipment

S&P 500

$140.66

Scores poorly across most models. Proceed with caution.

Weak

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#145out of 168 in Health Care

Is INSULET CORP a Good Investment in 2026?

INSULET CORP (PODD) scores 3.7 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates INSULET CORP as Strong (7/9). However, the Graham model rates it Caution — Significantly above fair value. INSULET CORP currently trades 32% above its estimated fair value of $107. INSULET CORP ranks #145 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E40.9ROE17.0Market Cap10B

Estimated Fair Value

$106.8132% above

Trading above estimated fair value. P/e of 41x implies high growth expectations. eps growth of -39% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 0.4 · Fast Grower

Greenblatt

Neutral

Earnings yield 4.0% · ROC 21%

Frequently Asked Questions

Is INSULET CORP (PODD) a good investment?
As of Sep 20, 2026, Insulet Corp (PODD) scores 3.7/10 on AlphaStocks' five-model composite, #145 of 168 Health Care stocks. At $141, PODD trades 32% above its model fair value of $107. That score is below average, suggesting caution.
What is INSULET CORP's Piotroski F-Score?
INSULET CORP's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is PODD overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $107, PODD appears overvalued. The stock currently trades 32% above its estimated fair value. Trading above estimated fair value. P/e of 41x implies high growth expectations. eps growth of -39% may not justify the premium.
How does PODD compare to other Health Care stocks?
INSULET CORP ranks #145 out of 168 stocks in the Health Care sector, placing it in the top 86% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about PODD?
AlphaStocks evaluates PODD using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 3.7/10.

Similar Stocks

INSPUFPTBDX

Compare PODD with

INSP vs PODDPODD vs UFPTBDX vs PODDPODD vs VALPARR vs PODD

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer